Pharmacological Characterization of H05, a Novel Serotonin and Noradrenaline Reuptake Inhibitor with Moderate 5-HT2A Antagonist Activity for the Treatment of Depression [Neuropharmacology]

Xu, X., Wei, Y., Guo, Q., Zhao, S., Liu, Z., Xiao, T., Liu, Y., Qiu, Y., Hou, Y., Zhang, G., Wang, K.
The American Society for Pharmacology and Experimental Therapeutics
Published 2018